Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)
 
 • Company Description   
agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States.

Number of Employees: 856

 
 • Price / Volume Information   
Yesterday's Closing Price: $98.00 Daily Weekly Monthly
20 Day Moving Average: 325,707 shares
Shares Outstanding: 16.68 (millions)
Market Capitalization: $1,635.03 (millions)
Beta: 2.98
52 Week High: $133.04
52 Week Low: $7.48
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.62% -9.30%
12 Week 250.63% 241.02%
Year To Date 469.19% 438.13%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
440 Polaris Parkway Suite 550
-
Westerville,OH 43082
USA
ph: 562-256-3800
fax: -
investors@agilonhealth.com http://agilonhealth.com
 
 • General Corporate Information   
Officers
Ronald A. Williams - Chairman
Ravi Sachdev - Vice Chairman
Jeffrey Schwaneke - Chief Financial Officer
Timothy Gertsch - Chief Accounting Officer
Sharad Mansukani - Director

Peer Information
Agilon Health, Inc. (CHCR)
Agilon Health, Inc. (ESRX)
Agilon Health, Inc. (MYDP)
Agilon Health, Inc. (COR)
Agilon Health, Inc. (GBCS)
Agilon Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 00857U206
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/05/26
Share - Related Items
Shares Outstanding: 16.68
Most Recent Split Date: 3.00 (0.04:1)
Beta: 2.98
Market Capitalization: $1,635.03 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.62 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-3.50 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 53.28% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 9.00
Price/Cash Flow: -
Price / Sales: 0.28
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 115.65%
Sales Growth
vs. Year Ago Period: -7.33%
vs. Previous Quarter: -9.50%
ROE
06/30/26 - -
03/31/26 - -146.03
12/31/25 - -120.82
ROA
06/30/26 - -
03/31/26 - -24.55
12/31/25 - -24.89
Current Ratio
06/30/26 - -
03/31/26 - 1.04
12/31/25 - 1.02
Quick Ratio
06/30/26 - -
03/31/26 - 1.04
12/31/25 - 1.02
Operating Margin
06/30/26 - -
03/31/26 - -6.42
12/31/25 - -6.83
Net Margin
06/30/26 - -
03/31/26 - -6.09
12/31/25 - -6.60
Pre-Tax Margin
06/30/26 - -
03/31/26 - -6.40
12/31/25 - -6.81
Book Value
06/30/26 - -
03/31/26 - 10.89
12/31/25 - 7.64
Inventory Turnover
06/30/26 - -
03/31/26 - -
12/31/25 - -
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.08
12/31/25 - 0.12
Debt-to-Capital
06/30/26 - -
03/31/26 - 7.77
12/31/25 - 11.05
 

Powered by Zacks Investment Research ©